138 related articles for article (PubMed ID: 32618052)
41. Primary Diagnoses of Squamous Cell Carcinoma of the Head and Neck During the COVID-19 Pandemic.
Hintschich CA; Gerken M; Spoerl S; Bohr C; Künzel J
Dtsch Arztebl Int; 2023 Oct; 120(42):719-720. PubMed ID: 37970707
[No Abstract] [Full Text] [Related]
42. Academic Affiliation and Surgical Volume Predict Survival in Head and Neck Cancer Patients Receiving Surgery.
Farquhar DR; Masood MM; Lenze NR; Sheth S; Patel SN; Lumley C; Zanation AM; Weissler MC; Olshan AF; Hackman TG
Laryngoscope; 2021 Feb; 131(2):E479-E488. PubMed ID: 32449832
[TBL] [Abstract][Full Text] [Related]
43. Palliative treatment standards for head and neck squamous cell carcinoma : Survey of clinical routine in German-speaking countries.
Laban S; Kimmeyer J; Knecht R; Hoffmann TK; Busch CJ; Veit JA; Möckelmann N; Kurzweg T
HNO; 2016 Jul; 64(7):487-93. PubMed ID: 27299894
[TBL] [Abstract][Full Text] [Related]
44. Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Goel R; Moore W; Sumer B; Khan S; Sher D; Subramaniam RM
AJR Am J Roentgenol; 2017 Aug; 209(2):289-303. PubMed ID: 28731808
[TBL] [Abstract][Full Text] [Related]
45. Liver function tests: inadequate screening modality for detection of liver metastasis in head and neck carcinoma.
Deal AM; Patel MR; Thorp BD; Cannon TY; Shores CG; Zanation AM
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):88-91. PubMed ID: 21987648
[TBL] [Abstract][Full Text] [Related]
46. The COVID-19 pandemic and its consequences for the diagnosis and therapy of head and neck malignancies.
Balk M; Rupp R; Craveiro AV; Allner M; Grundtner P; Eckstein M; Hecht M; Iro H; Gostian AO
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):284-290. PubMed ID: 35049006
[TBL] [Abstract][Full Text] [Related]
47. A New Approach to Survival Analysis of Head and Neck Squamous Cell Carcinoma.
Masoudi S; Montazeri SA; Pourdanesh F; Biglarian A; Kazemi M; Rahgozar M
Arch Iran Med; 2017 Aug; 20(8):503-510. PubMed ID: 28846014
[TBL] [Abstract][Full Text] [Related]
48. Advanced Cutaneous Squamous Cell Carcinoma Is Associated with Suboptimal Initial Management in a Cohort of 109 Patients.
Deilhes F; Boulinguez S; Pagès C; Paul C; Meyer N
Dermatology; 2019; 235(6):516-521. PubMed ID: 31387094
[TBL] [Abstract][Full Text] [Related]
49. [Current trends in diagnosis and treatment head and neck cancer].
Lacau St Guily JL
Rev Prat; 2006 Oct; 56(15):1652-7. PubMed ID: 17137249
[TBL] [Abstract][Full Text] [Related]
50. Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.
Wang YK; Chuang YS; Wu TS; Lee KW; Wu CW; Wang HC; Kuo CT; Lee CH; Kuo WR; Chen CH; Wu DC; Wu IC
Int J Cancer; 2017 Nov; 141(10):1987-1996. PubMed ID: 28758200
[TBL] [Abstract][Full Text] [Related]
51. Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma.
Kim DH; Gong EJ; Jung HY; Lim H; Ahn JY; Choi KS; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY; Baek S
Scand J Gastroenterol; 2014 Dec; 49(12):1486-92. PubMed ID: 25372595
[TBL] [Abstract][Full Text] [Related]
52. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
53. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
54. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.
Kwon M; Kim RB; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Head Neck; 2017 Apr; 39(4):716-723. PubMed ID: 28000343
[TBL] [Abstract][Full Text] [Related]
56. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
[TBL] [Abstract][Full Text] [Related]
57. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
58. Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.
Abdel Razek AAK; Nada N
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1301-1307. PubMed ID: 29582174
[TBL] [Abstract][Full Text] [Related]
59. Incidence of head and neck squamous cell carcinoma among subjects at high risk of lung cancer: results from the Pittsburgh Lung Screening Study.
Dixit R; Weissfeld JL; Wilson DO; Balogh P; Sufka P; Siegfried JM; Grandis JR; Diergaarde B
Cancer; 2015 May; 121(9):1431-5. PubMed ID: 25559556
[TBL] [Abstract][Full Text] [Related]
60. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
